DOI 10.1007/s12094-025-04111-9
Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived from saline flushes collected during routine EUS-FNA.
Аннотация
PURPOSE: To evaluate the in vitro drug sensitivity of patient-derived cancer organoids (PDCOs) established from residual samples from saline flushes (RSSF) collected during routine endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in patients with pancreatic cancer.
METHODS
Organoids were cultured under mutation-selective conditions. IC50 values for 5-fluorouracil (5-FU), SN-38, oxaliplatin, gemcitabine, and paclitaxel were calculated.
RESULTS
PDCOs showed variable responses to the drugs. Exploratory quantitative analysis using ordinal sensitivity scoring and ROC curves (Area under the curve [AUC] up to 0.917) indicated that lower in vitro IC₅₀ scores tended to associate with clinical responders (PR/uPR) compared with non-responders (progressive or stable disease [PD/SD]).
CONCLUSIONS
This study demonstrated the feasibility and potential usefulness of in vitro drug sensitivity profiling of pancreatic cancer using RSSF-derived PDCOs. These findings represent the first step toward clinical application, and further validation in larger cohorts is warranted.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.